Company overview
Basic information
Company name
SkinTech MPT, MB
Company code
307130857
VAT code
LT100017703913
Registered address
Vilnius, Girulių g. 10, LT-12112
Registration date
2025-03-25
Company age: 1 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other engineering activities and related technical consultancy
Ownership form
Private without foreign capital
MB "SkinTech MPT"
Company code: 307130857
Address: Vilnius, Girulių g. 10, LT-12112
VAT code: LT100017703913
Description
This description was generated by artificial intelligence.
SkinTech MPT, MB (company code 307130857) is a private small partnership registered in 2025 and currently operational. It is a micro-sized company with a CEO-only governance structure and belongs to the sector of national private non-financial companies. The ownership form is private, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company is based in Vilnius, Giruliu g. 10, LT-12112, in Vilnius city municipality, Vilnius County. Its registered activity under EVRK code N.71.12.90 is Other engineering activities and related technical consultancy. In its 2025 financial year, which covered 281 days, the company generated revenue of EUR 120.0K and net profit of EUR 74.3K, resulting in a profit margin of 61.9%. At year-end 2025, equity stood at EUR 74.4K, liabilities at EUR 36.6K, and total assets at EUR 111.0K. The balance sheet was composed of EUR 41.3K in long-term assets and EUR 69.7K in short-term assets. Reported financial ratios for 2025 indicate strong profitability and a solid equity position.
Download a detailed company report
Make confident decisions with all the information about SkinTech MPT, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.